DK1121375T3 - (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-on i høj renhedsgrad - Google Patents

(7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-on i høj renhedsgrad

Info

Publication number
DK1121375T3
DK1121375T3 DK99948994T DK99948994T DK1121375T3 DK 1121375 T3 DK1121375 T3 DK 1121375T3 DK 99948994 T DK99948994 T DK 99948994T DK 99948994 T DK99948994 T DK 99948994T DK 1121375 T3 DK1121375 T3 DK 1121375T3
Authority
DK
Denmark
Prior art keywords
7alpha
17alpha
pregn
hydroxy
methyl
Prior art date
Application number
DK99948994T
Other languages
Danish (da)
English (en)
Inventor
Peter Huub Gerard Kirchholtes
Gerard Arnoud Jozef Maria Sas
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8234220&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1121375(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK1121375T3 publication Critical patent/DK1121375T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK99948994T 1998-10-16 1999-10-11 (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-on i høj renhedsgrad DK1121375T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203460 1998-10-16
PCT/EP1999/007768 WO2000023460A1 (en) 1998-10-16 1999-10-11 HIGH PURITY COMPOSITION COMPRISING (7α,17α)- 17-HYDROXY- 7-METHYL- 19-NOR-17-PREGN- 5(10)-EN-20-YN-3-ONE

Publications (1)

Publication Number Publication Date
DK1121375T3 true DK1121375T3 (da) 2003-08-04

Family

ID=8234220

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99948994T DK1121375T3 (da) 1998-10-16 1999-10-11 (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-on i høj renhedsgrad

Country Status (30)

Country Link
US (3) US6969708B1 (cs)
EP (2) EP1275379A3 (cs)
JP (1) JP2002527525A (cs)
KR (3) KR20050003358A (cs)
CN (2) CN100432093C (cs)
AR (1) AR020832A1 (cs)
AT (1) ATE239032T1 (cs)
AU (1) AU763232B2 (cs)
BR (1) BR9914441A (cs)
CA (1) CA2344686C (cs)
CO (1) CO5160271A1 (cs)
CZ (1) CZ298703B6 (cs)
DE (1) DE69907495T2 (cs)
DK (1) DK1121375T3 (cs)
ES (1) ES2197677T3 (cs)
HK (1) HK1039620B (cs)
HU (1) HUP0104206A3 (cs)
ID (1) ID28463A (cs)
IL (1) IL141850A (cs)
NO (1) NO317427B1 (cs)
NZ (1) NZ510501A (cs)
PE (1) PE20001377A1 (cs)
PL (1) PL197870B1 (cs)
PT (1) PT1121375E (cs)
RU (1) RU2220975C2 (cs)
SK (1) SK284569B6 (cs)
TR (2) TR200504091T2 (cs)
TW (2) TW577893B (cs)
WO (1) WO2000023460A1 (cs)
ZA (1) ZA200101952B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL356465A1 (en) * 2002-10-04 2004-04-05 ANPHARM Przedsiębiorstwo Farmaceutyczne S.A. METHOD OF MANUFACTURE OF 17beta-HYDROXY-7alpha-METHYL-19-NOR-17alpha-PREGN-5(10)-ENE-20-YNE-3-ONE
TW200418525A (en) * 2002-11-20 2004-10-01 Akzo Nobel Nv Coated pharmaceutical tablets containing Tibolone
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
WO2005117899A1 (en) * 2004-06-02 2005-12-15 Cipla Limited Pharmaceutical composition comprising tibolone and process for procuding the same
WO2006081962A1 (en) 2005-02-01 2006-08-10 F.Hoffmann-La Roche Ag Ibandronate polymorph b
KR100908529B1 (ko) * 2005-02-01 2009-07-20 에프. 호프만-라 로슈 아게 이반드로네이트 다형체 에이
WO2006125453A1 (en) * 2005-05-23 2006-11-30 Newchem S.P.A. Process for the preparation of pure crystalline tibolone
CZ300465B6 (cs) * 2007-07-25 2009-05-27 Zentiva, A. S. Zpusob výroby komprimované farmaceutické formulace s obsahem tibolonu
ITMI20130120A1 (it) * 2013-01-25 2014-07-26 Ind Chimica Srl Processo per la preparazione in forma cristallina di tibolone, (7alfa,17alfa)-17-idrossi-7-metil-19-norpregn-5(10)-en-20-in-3-one
CA3122854A1 (en) * 2018-12-17 2020-06-25 Aimmune Therapeutics, Inc. Formulations for egg oral immunotherapy, methods of manufacture, and treatments for egg allergy
CN114409717B (zh) * 2021-12-17 2023-03-17 湖南科益新生物医药有限公司 替勃龙中间体醚化物和替勃龙的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665514A (cs) * 1964-06-16
CH488682A (de) 1965-07-30 1970-04-15 Ciba Geigy Verfahren zur Herstellung von 4,9,11-Trienen der 19-Nor-androstanreihe
NL146838B (nl) 1966-06-24 1975-08-15 Organon Nv Werkwijze voor het bereiden van (delta)5(10)-3- keto-19-norsteroiden.
US3515719A (en) 1967-03-15 1970-06-02 Upjohn Co 7-methyl-6,19-epoxy steroids of the androstane series
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
JPH03503414A (ja) * 1988-03-25 1991-08-01 アクゾ・エヌ・ヴエー フッ化物塩を含有する医薬製剤
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
DK0613687T3 (da) * 1993-03-05 1999-12-06 Akzo Nobel Nv Anvendelse af pregnanderivat til behandling af tumorer
CA2159419C (en) 1994-10-17 2006-07-04 Pieter De Haan Solid pharmaceutical composition comprising an excipient capable of binding water
IL123422A (en) * 1997-03-05 2003-05-29 Akzo Nobel Nv USE OF 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PROPHYLAXIS OR THE TREATMENT OF ATHEROSCLEROSIS
IL123984A (en) * 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable

Also Published As

Publication number Publication date
KR20010080133A (ko) 2001-08-22
EP1121375B1 (en) 2003-05-02
JP2002527525A (ja) 2002-08-27
CN100432093C (zh) 2008-11-12
HK1039620A1 (en) 2002-05-03
ES2197677T3 (es) 2004-01-01
PL347264A1 (en) 2002-03-25
BR9914441A (pt) 2001-06-26
PL197870B1 (pl) 2008-05-30
EP1275379A3 (en) 2003-03-26
HUP0104206A2 (hu) 2002-04-29
TR200101083T2 (tr) 2001-08-21
SK284569B6 (sk) 2005-06-02
CZ2001976A3 (cs) 2001-08-15
NO20011664L (no) 2001-04-03
IL141850A0 (en) 2002-03-10
TR200504091T2 (tr) 2006-05-22
US6969708B1 (en) 2005-11-29
NO317427B1 (no) 2004-10-25
EP1275379A2 (en) 2003-01-15
TW200403251A (en) 2004-03-01
EP1121375A1 (en) 2001-08-08
DE69907495D1 (de) 2003-06-05
NO20011664D0 (no) 2001-04-03
KR100635018B1 (ko) 2006-10-17
CN1322210A (zh) 2001-11-14
CN1769293A (zh) 2006-05-10
AU6202999A (en) 2000-05-08
IL141850A (en) 2005-11-20
HK1039620B (en) 2003-08-22
US20050245496A1 (en) 2005-11-03
DE69907495T2 (de) 2004-05-06
HUP0104206A3 (en) 2002-06-28
KR20050003358A (ko) 2005-01-10
PT1121375E (pt) 2003-07-31
PE20001377A1 (es) 2000-12-09
NZ510501A (en) 2003-10-31
ZA200101952B (en) 2002-06-10
ID28463A (id) 2001-05-24
RU2220975C2 (ru) 2004-01-10
CA2344686A1 (en) 2000-04-27
CN100378116C (zh) 2008-04-02
SK4932001A3 (en) 2001-12-03
AR020832A1 (es) 2002-05-29
WO2000023460A1 (en) 2000-04-27
TW577893B (en) 2004-03-01
AU763232B2 (en) 2003-07-17
US20040248870A1 (en) 2004-12-09
ATE239032T1 (de) 2003-05-15
CO5160271A1 (es) 2002-05-30
CZ298703B6 (cs) 2007-12-27
CA2344686C (en) 2009-04-28
KR20060071897A (ko) 2006-06-27

Similar Documents

Publication Publication Date Title
PT1114031E (pt) 4-carboxiamino-1,2,3,4-tetradhiroquinolinas substituidas em posicao 2
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
PT1015467E (pt) Derivados de eritromicina em ponte 6,9-
DE69917327D1 (de) 3,3-biarylpiperidin- und 3,3-biarylmorpholinderivate
DK1121375T3 (da) (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-on i høj renhedsgrad
ID26909A (id) Turunan-turunan 1,3,4-oksadiazolon
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
DE69521515D1 (de) Quantenkryptographie
ATE234839T1 (de) 4,5-azolo-oxindole
MA24648A1 (fr) Electrolyseur
NO20004167D0 (no) Kaspase-8 interagerende proteiner
ATE234302T1 (de) Di- oder triazaspiro(4,5)decanderivate
DE69926606D1 (de) Plazentaprotein 13
FI980759A0 (fi) Taetningskonstruktion foer suglaodan i en sugvals
DE69934804D1 (de) Supraleiter
ID26368A (id) Turunan-turunan 2 deoksi higromisin
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
DE69915055D1 (de) Antitumorale 1,5-diazaanthraquinone
DE69908923D1 (de) 1,3,4-thiadiazolylazofarbstoffe-enthaltende tintenzusammensetzungen
BR7700792U (pt) Disposiç o construtiva em calceiro
ITPS990017V0 (it) Leeran 1 (lorean)